conv.

All stories
HealthQuiet 7d · day 7

CBS investigation finds Eli Lilly's unapproved weight loss drug Retatrutide sold illegally online

CBS News uncovers companies marketing and selling the experimental drug to U.S. consumers despite ongoing clinical trials.

newest coverage 7d agosummary written 7d ago3 pieces MastodonYouTubeNewswires

What to know

  • Retatrutide, an experimental drug still in clinical trials at Eli Lilly, is being illegally sold online to U.S. consumers.
  • The drug has not been approved for use outside of controlled clinical research settings.
  • CBS News' investigation uncovered the unauthorized marketing and sales operation.

Eli LillyEli Lilly Drug developerDaniel Gilbert CBS News investigative reporter

CBS investigation finds Eli Lilly's unapproved weight loss drug Retatrutide sold illegally online
CBS News

How it unfolded 1 development · click the chart to see its coverage articlesvideosposts

Peak 2 pieces in two hours at Sep 16, 7 PM; 3 pieces over 7 days (1 article · 1 video · 1 post) Sep 16, 5 PM — 1 piece · 1 post — Mastodon 1Sep 16, 7 PM — 2 pieces · 1 article · 1 video — Newswires 1, YouTube 1Sep 16, 9 PM — quietSep 16, 11 PM — quietSep 17, 1 AM — quietSep 17, 3 AM — quietSep 17, 5 AM — quietSep 17, 7 AM — quietSep 17, 9 AM — quietSep 17, 11 AM — quietSep 17, 1 PM — quietSep 17, 3 PM — quietSep 17, 5 PM — quietSep 17, 7 PM — quietSep 17, 9 PM — quietSep 17, 11 PM — quietSep 18, 1 AM — quietSep 18, 3 AM — quietSep 18, 5 AM — quietSep 18, 7 AM — quietSep 18, 9 AM — quietSep 18, 11 AM — quietSep 18, 1 PM — quietSep 18, 3 PM — quietSep 18, 5 PM — quietSep 18, 7 PM — quietSep 18, 9 PM — quietSep 18, 11 PM — quietSep 19, 1 AM — quietSep 19, 3 AM — quietSep 19, 5 AM — quietSep 19, 7 AM — quietSep 19, 9 AM — quietSep 19, 11 AM — quietSep 19, 1 PM — quietSep 19, 3 PM — quietSep 19, 5 PM — quietSep 19, 7 PM — quietSep 19, 9 PM — quietSep 19, 11 PM — quietSep 20, 1 AM — quietSep 20, 3 AM — quietSep 20, 5 AM — quietSep 20, 7 AM — quietSep 20, 9 AM — quietSep 20, 11 AM — quietSep 20, 1 PM — quietSep 20, 3 PM — quietSep 20, 5 PM — quietSep 20, 7 PM — quietSep 20, 9 PM — quietSep 20, 11 PM — quietSep 21, 1 AM — quietSep 21, 3 AM — quietSep 21, 5 AM — quietSep 21, 7 AM — quietSep 21, 9 AM — quietSep 21, 11 AM — quietSep 21, 1 PM — quietSep 21, 3 PM — quietSep 21, 5 PM — quietSep 21, 7 PM — quietSep 21, 9 PM — quietSep 21, 11 PM — quietSep 22, 1 AM — quietSep 22, 3 AM — quietSep 22, 5 AM — quietSep 22, 7 AM — quietSep 22, 9 AM — quietSep 22, 11 AM — quietSep 22, 1 PM — quietSep 22, 3 PM — quietSep 22, 5 PM — quietSep 22, 7 PM — quietSep 22, 9 PM — quietSep 22, 11 PM — quietYesterday, 1 AM — quietYesterday, 3 AM — quietYesterday, 5 AM — quietYesterday, 7 AM — quietYesterday, 9 AM — quietYesterday, 11 AM — quietYesterday, 1 PM — quietYesterday, 3 PM — quietYesterday, 5 PM — quietYesterday, 7 PM — quietYesterday, 9 PM — quietYesterday, 11 PM — quietToday, 1 AM — quietToday, 3 AM — quiet 1
Sep 17Sep 18Sep 19Sep 20Sep 21Sep 22yesterdaynow · 4:44 AM ET
  1. 1

    CBS News investigation uncovers illegal online sales of Retatrutide

    CBS News investigative reporter Daniel Gilbert breaks news that Retatrutide, an unapproved experimental weight loss drug still undergoing clinical trials at Eli Lilly, is being illegally marketed and sold online to U.S. clients.

    “Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lily, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found.”
    — CBS News · source